Cargando…

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes. Social media platforms’ users started promoting semaglutide/Ozempic as a weight-loss treatment, and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arillotta, Davide, Floresta, Giuseppe, Guirguis, Amira, Corkery, John Martin, Catalani, Valeria, Martinotti, Giovanni, Sensi, Stefano L., Schifano, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669484/ https://www.ncbi.nlm.nih.gov/pubmed/38002464 http://dx.doi.org/10.3390/brainsci13111503

Ejemplares similares

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach
por: Catalani, Valeria, et al.
Publicado: (2021)

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
por: Arillotta, Davide, et al.
Publicado: (2021)

Assessing the 2004–2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems
por: Schifano, Fabrizio, et al.
Publicado: (2019)

The Psychonauts’ World of Cognitive Enhancers
por: Napoletano, Flavia, et al.
Publicado: (2020)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases
por: Chiappini, Stefania, et al.
Publicado: (2022)

Alprazolam-related deaths in Scotland, 2004–2020
por: Corkery, John Martin, et al.
Publicado: (2022)

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity
por: Catalani, Valeria, et al.
Publicado: (2021)

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts’ Scenario
por: Arillotta, Davide, et al.
Publicado: (2020)

The e-Psychonauts’ ‘Spiced’ World; Assessment of the Synthetic  Cannabinoids’ Information Available Online
por: Zangani, Caroline, et al.
Publicado: (2020)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
por: Chiappini, Stefania, et al.
Publicado: (2023)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
por: Chiappini, Stefania, et al.
Publicado: (2022)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Schifano, Fabrizio, et al.
Publicado: (2019)

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
por: Chiappini, Stefania, et al.
Publicado: (2020)

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
por: Chiappini, Stefania, et al.
Publicado: (2021)

COVID-19: The Hidden Impact on Mental Health and Drug Addiction
por: Chiappini, Stefania, et al.
Publicado: (2020)

The Benzydamine Experience: A Systematic Review of Benzydamine Abuse
por: Stefania, Chiappini, et al.
Publicado: (2021)

What About Drug Checking? Systematic Review and Netnographic  Analysis of Social Media
por: Guirguis, Amira, et al.
Publicado: (2020)

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants
por: Schifano, Fabrizio, et al.
Publicado: (2021)

The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2017)

New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature
por: Chiappini, Stefania, et al.
Publicado: (2021)

Psychedelic Fauna for Psychonaut Hunters: A Mini-Review
por: Orsolini, Laura, et al.
Publicado: (2018)

Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population
por: Chiappini, Stefania, et al.
Publicado: (2023)

‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports
por: Orsolini, Laura, et al.
Publicado: (2020)

Piloting the UK’s First Home-Office-Licensed Pharmacist-Led Drug Checking Service at a Community Substance Misuse Service
por: Guirguis, Amira, et al.
Publicado: (2020)

Misuse of Anticholinergic Medications: A Systematic Review
por: Chiappini, Stefania, et al.
Publicado: (2022)

Exploration of the Use of New Psychoactive Substances by Individuals in Treatment for Substance Misuse in the UK
por: Gittins, Rosalind, et al.
Publicado: (2018)

The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
por: Sharif, Safia, et al.
Publicado: (2021)

Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
por: Munafò, Antonio, et al.
Publicado: (2022)

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances
por: Ramos, Camille, et al.
Publicado: (2020)

Assessing prevalence, knowledge and use of cognitive enhancers among university students in the United Arab Emirates: A quantitative study
por: Sharif, Safia, et al.
Publicado: (2022)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?
por: Amouyal, Chloé, et al.
Publicado: (2016)

Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction
por: Chiappini, Stefania, et al.
Publicado: (2021)

Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II
por: Chiappini, Stefania, et al.
Publicado: (2022)

Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service
por: Mullin, Anthony, et al.
Publicado: (2023)

The Cardiovascular Effects of GLP-1 Receptor Agonists
por: Okerson, Theodore, et al.
Publicado: (2012)

GLP-1 Receptor Agonists and Kidney Protection
por: Greco, Eulalia Valentina, et al.
Publicado: (2019)

Clinical Trial Highlights – GLP-1 agonists
por: McFarthing, Kevin, et al.
Publicado: (2020)

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
por: Ma, Xiaoxuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f3u6u75403mbrr30ddmfhf3js7